Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Key Genes and Prognostic Analysis in HER2+ Breast Cancer

1 Jan 2021

Abstract excerpt

Human epidermal growth factor 2 (HER2)+ breast cancer is considered the most dangerous type of breast cancers. Herein, we used bioinformatics methods to identify potential key genes in HER2+ breast cancer to enable its diagnosis, treatment, and prognosis prediction. Datasets of HER2+ breast cancer and normal tissue samples retrieved from Gene Expression Omnibus and The Cancer Genome Atlas databases were subjected...

Topics

Join the communities discussing this publication.

Bioinformatics and Genomic Networks
Cancer-related Molecular Pathways
Ferroptosis and cancer prognosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33499770
DOI: 10.1177/1533033820983298

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Key Genes and Prognostic Analysis in HER2+ Breast CancerPMID 33499770Read ↗

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysisSemantic proximity Read ↗

Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic MarkersSemantic proximity Read ↗

A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survivalSemantic proximity Read ↗

Identification of a risk prediction model for clinical prognosis in HER2 positive breast cancer patientsSemantic proximity Read ↗

Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysisSemantic proximity Read ↗

Analysis of the Prognosis Related Genes in HER2+ Breast Cancer Based on Weighted Gene Co-expression Network AnalysisSemantic proximity Read ↗

Bioinformatics Identification of Prognostic Factors Associated with Breast CancerSemantic proximity Read ↗

Bioinformatics Identification of Prognostic Factors Associated With Breast CancerSemantic proximity Read ↗

Identifying Biomarkers for Prognostic Treatment in Breast Cancer through Bioinformatics AnalysisSemantic proximity Read ↗

High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.Semantic proximity Read ↗

Integrated Bioinformatics Analysis of PALB2 Reveals Expression Patterns, Molecular Interactions, and Prognostic Significance in Breast CancerSemantic proximity Read ↗

Demystifying the Role of Prognostic Biomarkers in Breast Cancer through Integrated Transcriptome and Pathway Enrichment AnalysesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.